On lower fibrinogen threshold for fibrinogen replacement in plasma exchange: Perhaps for patients with no bleeding risk, but there are more shades of gray

Documents similaires

• Further thoughts on a lower fibrinogen threshold prior to therapeutic plasma exchange
  par: Kamran Urgun, et autres
  Publié: (2025)
• A lower fibrinogen threshold does not lead to increased bleeding risk in patients receiving therapeutic plasma exchange: A prospective single‐center analysis
  par: Amelework Wodajo, et autres
  Publié: (2024)
• Elevating the standards of hypofibrinogenemia in trauma: Higher thresholds of admission fibrinogen predict mortality and organ dysfunction
  par: Justin Richards, et autres
  Publié: (2026)
• The clinical use of cryoprecipitate and fibrinogen concentrate: A scoping review
  par: Aaron S. Hess, et autres
  Publié: (2026)
• Analyzing and modeling massive transfusion strategies and the role of fibrinogen—How much is the patient actually receiving?
  par: Nadia M. Keltner, et autres
  Publié: (2024)